- Title
- Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus
- Authors/Creators
- M.C. Porter (Author/Creator) - Pathwest Laboratory MedicineB.A. Henderson (Author/Creator) - Pathwest Laboratory MedicineP.E. Healy (Author/Creator) - Pathwest Laboratory MedicineG.W. Coombs (Author/Creator) - Pathwest Laboratory MedicineP.R. Ingram (Author/Creator) - Pathwest Laboratory MedicineD. McLellan (Author/Creator) - Fremantle HospitalB. Clark (Author/Creator) - The University of Western Australia
- Publication Details
- Journal of Antimicrobial Chemotherapy, Vol.69(3), pp.856-857
- Publisher
- Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy
- Identifiers
- 991005543110107891
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
- Note
- Research letter
Journal article
Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Vol.69(3), pp.856-857
2014
Details
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
28 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.23 Antibiotics & Antimicrobials
- 1.23.173 MRSA and VRE
- Web Of Science research areas
- Infectious Diseases
- Microbiology
- Pharmacology & Pharmacy
- ESI research areas
- Pharmacology & Toxicology